艾滋病病毒封闭多肽 (HIV p55+Capsid protein p24) 

别    名:HIV p55+Capsid protein p24; HIV1 p55 + p24 + p17; CA antibody Capsid protein p24; Gag; Gag polyprotein; HIV1 matrix protein p17; HIV1 Pr55Gag; Human immunodeficiency virus 1 p17; Human immunodeficiency virus 1 p55; Human immunodeficiency virus type 1 p24; MA antibody Matrix protein; Matrix protein p17; Pr55; Pr55Gag; POL_HV1H2.  

Catalog Number:

LM812290DT

General Information

Species:

human

QC Testing

Activity:

Not tested

Purification:

HIV

Usage Guide

Storage:

Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.

Background:

bs-0241P is one synthetic peptide derived from HIV1 Surface protein gp120.
The attachment of enveloped viruses to cells and the fusion of viral and cellular membranes are critical early events in the HIV viral infection. This process is mediated by envelope glycoproteins (gp) on the surface of the virus. The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein, gp160, is proteolytically cleaved into gp120 and gp41, which remain noncovalently associated with one another. gp120 is one of the proteins that forms the envelope of HIV. gp120 projects from the surface of HIV and binds to the CD4 molecule on helper T cells. gp120 has been a logical experimental HIV vaccine because the outer envelope is the first part of the virus that encounters antibody. gp41 is embedded in the outer envelope of HIV that anchors gp120. gp41 also plays a key role in HIV's infection of CD4+ T cells by facilitating the fusion of the viral and cell membranes. The nomenclature of the gp proteins describes their respective molecular masses (e.g., gp160, gp120, gp41).

Figures

VALIDATION IMAGES

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

本产品只适用于科研，不能用于临床诊断。严禁用于临床医疗及其他非科研用途！以实际收货产品说明书为准，网站说明书仅供参考。